Evidence map›Paper›PMID 17122019›Full record

ArticleJournal of clinical microbiology2007

Magnetic silica extraction for low-viremia human immunodeficiency virus type 1 genotyping.

D R McClernon, E Ramsey, M St Clair

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

D R McClernonClinical Virology Department, GlaxoSmithKline, P.O. Box 13398, Research Triangle Park, NC 27709-3398, USA. daniel.r.mcclernon@gsk.com
E Ramsey
M St Clair

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid extraction and human immunodeficiency virus type 1 (HIV-1) genotyping using the NucliSens miniMAG platform and the TruGene HIV-1 genotyping kit gave HIV-1 sequence data from HIV-1-negative plasma spiked with 100 copies/ml reference HIV-1 RNA and from low-viremia clinical samples (<500 copies/ml) without the need for ultracentrifugation or nested second-round PCR.

Indexed as

MagneticsSilicon DioxideGenotypeHIV-1HIV InfectionsHumansReagent Kits, DiagnosticRNA, ViralViral LoadViremiaReagent Kits, DiagnosticRNA, ViralSilicon Dioxide

Identifiers

PMID17122019
PMCPMC1829022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.